{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:48:40Z","timestamp":1793713720333,"version":"4.6.1"},"reference-count":181,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Immunoglobulin A vasculitis (IgAV), formerly known as Henoch-Sch\u00f6nlein purpura, is the most common systemic vasculitis in children, characterized by diverse clinical manifestations with a wide spectrum ranging from isolated cutaneous vasculitis to systemic involvement. The incidence of IgAV is geographically and ethnically variable, with a prevalence in autumn and winter, suggesting a driving role that genetic and environmental factors play in the disease. Although IgAV has a certain degree of natural remission, it varies widely among individuals. Some patients can suffer from severe renal involvement and even progress to end-stage renal disease. Its pathogenesis is complex and has not been fully elucidated. The formation of galactose-deficient IgA1 (Gd-IgA1) and related immune complexes plays a vital role in promoting the occurrence and development of IgAV nephritis. In addition, neutrophil activation is stimulated through the binding of IgA to the Fc alpha receptor I expressed on its surface, resulting in systemic vascular inflammation and tissue damage. Starting from the epidemiological characteristics, this article will review the role of immunological factors such as Gd-IgA1, autoantibodies, circulating immune complexes, complement system, cellular immunization, and the contributions of environmental and genetic factors in the pathogenesis of IgAV, and conclude with the major biomarkers for IgAV.<\/jats:p>","DOI":"10.3389\/fimmu.2022.921864","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T06:03:57Z","timestamp":1664777037000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":139,"title":["IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers"],"prefix":"10.3389","volume":"13","author":[{"given":"Liyun","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised international chapel hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/art.40375","article-title":"Nomenclature of cutaneous vasculitis: Dermatologic addendum to the 2012 revised international chapel hill consensus conference nomenclature of vasculitides","volume":"70","author":"Sunderkotter","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2014.126","article-title":"Henoch-Sch\u00f6nlein purpura nephritis in children","volume":"10","author":"Davin","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez041","article-title":"European Consensus-based recommendations for diagnosis and treatment of immunoglobulin a vasculitis-the SHARE initiative","volume":"58","author":"Ozen","year":"2019","journal-title":"Rheumatol (Oxford)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12519-014-0534-5","article-title":"Henoch-Sch\u00f6nlein purpura nephritis in children: incidence, pathogenesis and management","volume":"11","author":"Chen","year":"2015","journal-title":"World J Pediatr"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-017-0457-z","article-title":"Value of the Oxford classification of IgA nephropathy in children with Henoch-Sch\u00f6nlein purpura nephritis","volume":"31","author":"Xu","year":"2018","journal-title":"J Nephrol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-019-01726-5","article-title":"A retrospective analysis of children with Henoch-Sch\u00f6nlein purpura and re-evaluation of renal pathologies using Oxford classification","volume":"23","author":"Cakici","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.658845","article-title":"Using MEST-c scores and the international study of kidney disease in children classification to predict outcomes of Henoch-Sch\u00f6nlein purpura nephritis in children","volume":"9","author":"Wang","year":"2021","journal-title":"Front Pediatr"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1159\/000501459","article-title":"The clinicopathological characteristics of Henoch-Sch\u00f6nlein purpura nephritis with presentation of nephrotic syndrome","volume":"44","author":"Tan","year":"2019","journal-title":"Kidney Blood Press Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa921","article-title":"Impact of aging on phenotype and prognosis in IgA vasculitis","volume":"60","author":"Audemard-Verger","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000013883.99976.22","article-title":"Henoch-Sch\u00f6nlein purpura in adults: outcome and prognostic factors","volume":"13","author":"Pillebout","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/art.40178","article-title":"Characteristics and management of IgA vasculitis (Henoch-Sch\u00f6nlein) in adults: Data from 260 patients included in a French multicenter retrospective survey","volume":"69","author":"Audemard-Verger","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"16001","DOI":"10.1038\/nrdp.2016.1","article-title":"IgA nephropathy","volume":"2","author":"Lai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2021.2009554","article-title":"Clinical characteristics and associating risk factors of gastrointestinal perforation in children with IgA vasculitis","volume":"53","author":"Guo","year":"2021","journal-title":"Ann Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.853724","article-title":"New insights and challenges associated with IgA vasculitis and IgA vasculitis with nephritis-is it time to change the paradigm of the most common systemic vasculitis in childhood","volume":"10","author":"Jelusic","year":"2022","journal-title":"Front Pediatr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.771619","article-title":"Pathogenesis of IgA vasculitis: An up-To-Date review","volume":"12","author":"Song","year":"2021","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/ard.2009.116657","article-title":"EULAR\/PRINTO\/PRES criteria for Henoch-Sch\u00f6nlein purpura, childhood polyarteritis nodosa, childhood wegener granulomatosis and childhood takayasu arteritis: Ankara 2008. part II: Final classification criteria","volume":"69","author":"Ozen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex158","article-title":"Incidence of IgA vasculitis in children estimated by four-source capture-recapture analysis: A population-based study","volume":"56","author":"Piram","year":"2017","journal-title":"Rheumatol (Oxford)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/03009742.2017.1412497","article-title":"Epidemiology of primary systemic vasculitis in children: A population-based study from southern Sweden","volume":"47","author":"Mossberg","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh544","article-title":"A nationwide survey on epidemiological characteristics of childhood Henoch-Sch\u00f6nlein purpura in Taiwan","volume":"44","author":"Yang","year":"2005","journal-title":"Rheumatol (Oxford)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e32835d8e2a","article-title":"Epidemiology of immunoglobulin a vasculitis (Henoch-Sch\u00f6nlein): Current state of knowledge","volume":"25","author":"Piram","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218649","article-title":"Geospatial clustering of childhood IgA vasculitis and IgA vasculitis-associated nephritis","volume":"80","author":"Sapina","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11279-7","article-title":"Incidence of Henoch-Sch\u00f6nlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins","volume":"360","author":"Gardner-Medwin","year":"2002","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"152047","DOI":"10.1016\/j.semarthrit.2022.152047","article-title":"COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis","volume":"55","author":"Batu","year":"2022","journal-title":"Semin Arthritis Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-021-04950-y","article-title":"IgA vasculitis with nephritis: Update of pathogenesis with clinical implications","volume":"37","author":"Hastings","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/ki.2011.16","article-title":"Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Sch\u00f6nlein purpura nephritis","volume":"80","author":"Kiryluk","year":"2011","journal-title":"Kidney Int"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.03.029","article-title":"Galactose-deficient IgA1 in skin and serum from patients with skin-limited and systemic IgA vasculitis","volume":"81","author":"Neufeld","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01964.x","article-title":"The level of IgA antibodies to human umbilical vein endothelial cells can be enhanced by TNF-alpha treatment in children with Henoch-Sch\u00f6nlein purpura","volume":"130","author":"Yang","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/adc.78.3.240","article-title":"Soluble thrombomodulin and antibodies to bovine glomerular endothelial cells in patients with Henoch-Sch\u00f6nlein purpura","volume":"78","author":"Fujieda","year":"1998","journal-title":"Arch Dis Child"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.10.009","article-title":"New insights in the pathogenesis of immunoglobulin a vasculitis (Henoch-Sch\u00f6nlein purpura)","volume":"16","author":"Heineke","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1595-3","article-title":"Analysis of the b cell receptor repertoire in six immune-mediated diseases","volume":"574","author":"Bashford-Rogers","year":"2019","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.132.1.16","article-title":"Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues","volume":"132","author":"Crago","year":"1984","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv032","article-title":"Role of let-7b in the regulation of n-acetylgalactosaminyltransferase 2 in IgA nephropathy","volume":"30","author":"Serino","year":"2015","journal-title":"Nephrol Dial Transpl"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016091043","article-title":"Galactosylation of IgA1 is associated with common variation in C1GALT1","volume":"28","author":"Gale","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.99","article-title":"Interaction between variants of two glycosyltransferase genes in IgA nephropathy","volume":"76","author":"Zhu","year":"2009","journal-title":"Kidney Int"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.262438199","article-title":"A unique molecular chaperone cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase","volume":"99","author":"Ju","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2019.08.015","article-title":"Autoantibodies specific for galactose-deficient IgA1 in IgA vasculitis with nephritis","volume":"4","author":"Suzuki","year":"2019","journal-title":"Kidney Int Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm781","article-title":"External suppression causes the low expression of the cosmc gene in IgA nephropathy","volume":"23","author":"Qin","year":"2008","journal-title":"Nephrol Dial Transpl"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.512277","article-title":"Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes","volume":"289","author":"Suzuki","year":"2014","journal-title":"J Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00117","article-title":"The origin and activities of IgA1-containing immune complexes in IgA nephropathy","volume":"7","author":"Knoppova","year":"2016","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2017.07.002","article-title":"Inhibition of STAT3 signaling reduces IgA1 autoantigen production in IgA nephropathy","volume":"2","author":"Yamada","year":"2017","journal-title":"Kidney Int Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1159\/000505748","article-title":"Leukemia inhibitory factor signaling enhances production of galactose-deficient IgA1 in IgA nephropathy","volume":"6","author":"Yamada","year":"2020","journal-title":"Kidney Dis (Basel)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2011.02.004","article-title":"Innate control of b cell responses","volume":"32","author":"Cerutti","year":"2011","journal-title":"Trends Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"197548","DOI":"10.1155\/2014\/197548","article-title":"Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease","volume":"2014","author":"Reily","year":"2014","journal-title":"J Immunol Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/ni829","article-title":"DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL","volume":"3","author":"Litinskiy","year":"2002","journal-title":"Nat Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20032000","article-title":"TACI and BAFF-r mediate isotype switching in b cells","volume":"201","author":"Castigli","year":"2005","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-014-2807-6","article-title":"Toll-like receptors, immunoproteasome and regulatory T cells in children with Henoch-Sch\u00f6nlein purpura and primary IgA nephropathy","volume":"29","author":"Donadio","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.136965","article-title":"TLR7 in b cells promotes renal inflammation and gd-IgA1 synthesis in IgA nephropathy","volume":"5","author":"Zheng","year":"2020","journal-title":"JCI Insight"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.08.022","article-title":"TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy","volume":"97","author":"Makita","year":"2020","journal-title":"Kidney Int"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2018.77386","article-title":"Serum GDIgA1 levels in children with IgA nephropathy and Henoch-Sch\u00f6nlein nephritis","volume":"43","author":"Mizerska-Wasiak","year":"2018","journal-title":"Cent Eur J Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfx300","article-title":"Value of biomarkers for predicting immunoglobulin a vasculitis nephritis outcome in an adult prospective cohort","volume":"33","author":"Berthelot","year":"2018","journal-title":"Nephrol Dial Transpl"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115261","article-title":"Relationship between immune parameters and organ involvement in children with Henoch-Sch\u00f6nlein purpura","volume":"9","author":"Pan","year":"2014","journal-title":"PloS One"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.2008.02762.x","article-title":"Clinical impact of altered immunoglobulin levels in Henoch-Sch\u00f6nlein purpura","volume":"51","author":"Fretzayas","year":"2009","journal-title":"Pediatr Int"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/0020-1383(89)90084-3","article-title":"Eye injuries in coal mining","volume":"20","author":"Carreck","year":"1989","journal-title":"Injury"},{"key":"B55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10157-020-01968-8","article-title":"Serum levels of galactose-deficient IgA1 in Chinese children with IgA nephropathy, IgA vasculitis with nephritis, and IgA vasculitis","volume":"25","author":"Tang","year":"2021","journal-title":"Clin Exp Nephrol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv221","article-title":"Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy","volume":"30","author":"Yasutake","year":"2015","journal-title":"Nephrol Dial Transpl"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.10.019","article-title":"IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis","volume":"93","author":"Suzuki","year":"2018","journal-title":"Kidney Int"},{"key":"B58","doi-asserted-by":"publisher","first-page":"14026","DOI":"10.1038\/s41598-020-71101-y","article-title":"Glomerular galactose-deficient IgA1 expression analysis in pediatric patients with glomerular diseases","volume":"10","author":"Ishiko","year":"2020","journal-title":"Sci Rep"},{"key":"B59","doi-asserted-by":"publisher","first-page":"102490","DOI":"10.1016\/j.autrev.2020.102490","article-title":"Rituximab treatment for IgA vasculitis: A systematic review","volume":"19","author":"Hernandez-Rodriguez","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30550-0","article-title":"Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): A double-blind, randomised, placebo-controlled phase 2b trial","volume":"389","author":"Fellstrom","year":"2017","journal-title":"Lancet"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz151","article-title":"Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin a vasculitis nephritis","volume":"35","author":"Zhang","year":"2020","journal-title":"Nephrol Dial Transpl"},{"key":"B62","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1172\/JCI5535","article-title":"Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies","volume":"104","author":"Tomana","year":"1999","journal-title":"J Clin Invest"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012010053","article-title":"Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy","volume":"23","author":"Berthoux","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190967","article-title":"Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy","volume":"13","author":"Placzek","year":"2018","journal-title":"PloS One"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1084\/jem.191.11.1999","article-title":"Fcalpha receptor (CD89) mediates the development of immunoglobulin a (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-iga complexes in patients and CD89 transgenic mice","volume":"191","author":"Launay","year":"2000","journal-title":"J Exp Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.276","article-title":"Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases","volume":"80","author":"Tissandie","year":"2011","journal-title":"Kidney Int"},{"key":"B67","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10157-018-1582-2","article-title":"Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis","volume":"23","author":"Suzuki","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1172\/JCI38468","article-title":"Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity","volume":"119","author":"Suzuki","year":"2009","journal-title":"J Clin Invest"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0140-6736(79)92505-4","article-title":"IgA immune complexes in Henoch-Sch\u00f6nlein purpura","volume":"1979","author":"Levinsky","year":"8152","journal-title":"Lancet"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr149","article-title":"Immune complexes in acute adult-onset Henoch-Sch\u00f6nlein nephritis","volume":"26","author":"Hilhorst","year":"2011","journal-title":"Nephrol Dial Transpl"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1990.204","article-title":"Polymeric IgA and immune complex concentrations in IgA-related renal disease","volume":"38","author":"Jones","year":"1990","journal-title":"Kidney Int"},{"key":"B72","article-title":"Removal systems of immunoglobulin a and immunoglobulin a containing complexes in IgA nephropathy and cirrhosis patients. The role of asialoglycoprotein receptors","volume":"69","author":"Roccatello","year":"1993","journal-title":"Lab Invest"},{"key":"B73","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.trsl.2020.10.007","article-title":"CD71 mesangial IgA1 receptor and the progression of IgA nephropathy","volume":"230","author":"Jhee","year":"2021","journal-title":"Transl Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxr125","article-title":"Integrin alpha1\/beta1 and alpha2\/beta1 as a receptor for IgA1 in human glomerular mesangial cells in IgA nephropathy","volume":"24","author":"Kaneko","year":"2012","journal-title":"Int Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V9112048","article-title":"Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins","volume":"9","author":"Kokubo","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1084\/jem.20112005","article-title":"Transglutaminase is essential for IgA nephropathy development acting through IgA receptors","volume":"209","author":"Berthelot","year":"2012","journal-title":"J Exp Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232194","article-title":"A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Sch\u00f6nlein purpura nephritis and IgA nephropathy","volume":"15","author":"Sugiyama","year":"2020","journal-title":"PloS One"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1987.178","article-title":"Glomerular deposition of cross-linked fibrin in human kidney diseases","volume":"32","author":"Takemura","year":"1987","journal-title":"Kidney Int"},{"key":"B79","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12969-021-00616-z","article-title":"IgA vasculitis nephritis clinical course and kidney biopsy - national study in children","volume":"19","author":"Mizerska-Wasiak","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.3390\/jcm10112310","article-title":"IgA vasculitis and IgA nephropathy: Same disease","volume":"10","author":"Pillebout","year":"2021","journal-title":"J Clin Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00565.x","article-title":"What is the difference between IgA nephropathy and Henoch-Sch\u00f6nlein purpura nephritis","volume":"59","author":"Davin","year":"2001","journal-title":"Kidney Int"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaa129","article-title":"Evaluation of the Oxford classification in immunoglobulin a vasculitis with nephritis: A cohort study and meta-analysis","volume":"14","author":"Yu","year":"2021","journal-title":"Clin Kidney J"},{"key":"B83","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12969-019-0311-z","article-title":"Different histological classifications for Henoch-Sch\u00f6nlein purpura nephritis: which one should be used","volume":"17","author":"Jelusic","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-019-04363-y","article-title":"Histological prognostic factors in children with Henoch-Sch\u00f6nlein purpura nephritis","volume":"35","author":"Delbet","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-007-0332-7","article-title":"The role of chemokines in henoch schonlein purpura","volume":"27","author":"Tahan","year":"2007","journal-title":"Rheumatol Int"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711730208","article-title":"Pathogenesis of IgA nephropathy: in vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion","volume":"173","author":"Chen","year":"1994","journal-title":"J Pathol"},{"key":"B87","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.153.11.5247","article-title":"Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation","volume":"153","author":"Gomez-Guerrero","year":"1994","journal-title":"J Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.06-10-03079.1986","article-title":"Polyribosomes associated with synaptic specializations on axon initial segments: Localization of protein-synthetic machinery at inhibitory synapses","volume":"6","author":"Steward","year":"1986","journal-title":"J Neurosci"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2022.01.011","article-title":"Lectin and alternative complement pathway activation in cutaneous manifestations of IgA-vasculitis: A new target for therapy","volume":"143","author":"Damman","year":"2022","journal-title":"Mol Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.semnephrol.2007.10.007","article-title":"The role of secretory IgA and complement in IgA nephropathy","volume":"28","author":"Oortwijn","year":"2008","journal-title":"Semin Nephrol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-011-2070-z","article-title":"Henoch-Sch\u00f6nlein purpura with hypocomplementemia","volume":"27","author":"Lin","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70192-2","article-title":"Complement activation through the lectin pathway in patients with Henoch-Sch\u00f6nlein purpura nephritis","volume":"35","author":"Endo","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"B93","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1053\/j.ajkd.2004.10.020","article-title":"Activation of the lectin complement pathway in Henoch-Sch\u00f6nlein purpura nephritis","volume":"45","author":"Hisano","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1159\/000508841","article-title":"Inhibition of the lectin pathway of the complement system as a novel approach in the management of IgA vasculitis-associated nephritis","volume":"144","author":"Selvaskandan","year":"2020","journal-title":"Nephron"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0259-z","article-title":"Complement-mediated microangiopathy in IgA nephropathy and IgA vasculitis with nephritis","volume":"32","author":"Chua","year":"2019","journal-title":"Mod Pathol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005090923","article-title":"Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease","volume":"17","author":"Roos","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn563","article-title":"Mesangial C4d deposition: A new prognostic factor in IgA nephropathy","volume":"24","author":"Espinosa","year":"2009","journal-title":"Nephrol Dial Transpl"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02166","article-title":"Complement inhibitors in clinical trials for glomerular diseases","volume":"10","author":"Zipfel","year":"2019","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1212","article-title":"Involvement of activated cytotoxic T lymphocytes and natural killer cells in Henoch-Sch\u00f6nlein purpura nephritis","volume":"9","author":"Imai","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaut.2019.01.012","article-title":"Recruitment of CXCR3(+) T cells into injured tissues in adult IgA vasculitis patients correlates with disease activity","volume":"99","author":"Audemard-Verger","year":"2019","journal-title":"J Autoimmun"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.03.029","article-title":"Evaluation of T helper-1\/-2 balance on the basis of IgG subclasses and serum cytokines in children with glomerulonephritis","volume":"44","author":"Kawasaki","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013991","article-title":"The change of Th17\/Treg cells and IL-10\/IL-17 in Chinese children with Henoch-Sch\u00f6nlein purpura: A PRISMA-compliant meta-analysis","volume":"98","author":"Li","year":"2019","journal-title":"Med (Baltimore)"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa752","article-title":"Deficiency in the frequency and function of Tr1 cells in IgAV and the possible role of IL-27","volume":"60","author":"Pan","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B104","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.intimp.2015.12.037","article-title":"A higher frequency of CD4(+)CXCR5(+) T follicular helper cells in patients with newly diagnosed Henoch-Sch\u00f6nlein purpura nephritis","volume":"32","author":"Zhang","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12865-016-0176-6","article-title":"Distinct phenotypic subpopulations of circulating CD4(+)CXCR5(+) follicular helper T cells in children with active IgA vasculitis","volume":"17","author":"Liu","year":"2016","journal-title":"BMC Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4234-8","article-title":"Insight into inflammatory cell and cytokine profiles in adult IgA vasculitis","volume":"38","author":"Kuret","year":"2019","journal-title":"Clin Rheumatol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-019-04415-4","article-title":"Serum levels of selected cytokines [interleukin (IL)-17A, IL-18, IL-23] and chemokines (RANTES, IP10) in the acute phase of immunoglobulin a vasculitis in children","volume":"39","author":"Jaszczura","year":"2019","journal-title":"Rheumatol Int"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100924","article-title":"Systemic activation of neutrophils by immune complexes is critical to IgA vasculitis","volume":"15","author":"Mayer-Hain","year":"2022","journal-title":"J Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2013.05.053","article-title":"High glucose modulates IL-6 mediated immune homeostasis through impeding neutrophil extracellular trap formation","volume":"587","author":"Joshi","year":"2013","journal-title":"FEBS Lett"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.12.012","article-title":"Anti-endothelial cell antibodies in vasculitis: A systematic review","volume":"16","author":"Legendre","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1990.tb05431.x","article-title":"Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis","volume":"82","author":"Frampton","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-004-0910-y","article-title":"The significance of IgA class of antineutrophil cytoplasmic antibodies (ANCA) in childhood Henoch-Sch\u00f6nlein purpura","volume":"23","author":"Ozaltin","year":"2004","journal-title":"Clin Rheumatol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400322","article-title":"Endothelial cells as target for antiphospholipid antibodies. human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation","volume":"40","author":"Del Papa","year":"1997","journal-title":"Arthritis Rheumatol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2006.03076.x","article-title":"Circulating IgA from acute stage of childhood Henoch-Sch\u00f6nlein purpura can enhance endothelial interleukin (IL)-8 production through MEK\/ERK signalling pathway","volume":"144","author":"Yang","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12337","article-title":"The era of the immunoglobulin a fc receptor FcalphaRI; its function and potential as target in disease","volume":"268","author":"Aleyd","year":"2015","journal-title":"Immunol Rev"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-012-1268-7","article-title":"Elevated serum interleukin-33 levels in patients with Henoch-Sch\u00f6nlein purpura","volume":"305","author":"Chen","year":"2013","journal-title":"Arch Dermatol Res"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.111.231431","article-title":"Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques","volume":"31","author":"Demyanets","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012217","article-title":"Analysis of seasonal tendencies in pediatric Henoch-Sch\u00f6nlein purpura and comparison with outbreak of infectious diseases","volume":"97","author":"Hwang","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.5409\/wjcp.v5.i1.82","article-title":"Current views of the relationship between helicobacter pylori and Henoch-Sch\u00f6nlein purpura in children","volume":"5","author":"Xiong","year":"2016","journal-title":"World J Clin Pediatr"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)90426-3","article-title":"Schonlein-henoch purpura associated with gastric helicobacter pylori infection","volume":"33","author":"Reinauer","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2019.07.004","article-title":"Association of the infectious triggers with childhood Henoch-Sch\u00f6nlein purpura in anhui province, China","volume":"13","author":"Wang","year":"2020","journal-title":"J Infect Public Health"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06566.x","article-title":"Prevalence of human parvovirus B19 component NS1 gene in patients with Henoch-Sch\u00f6nlein purpura and hypersensitivity vasculitis","volume":"152","author":"Ohtsuka","year":"2005","journal-title":"Br J Dermatol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1042\/bst0250486","article-title":"Origin and structure of pathogenic IgA in IgA nephropathy","volume":"25","author":"Allen","year":"1997","journal-title":"Biochem Soc Trans"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1159\/000324607","article-title":"Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: Role of mucosal immune system","volume":"72","author":"Novak","year":"2011","journal-title":"Adv Otorhinolaryngol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16211","article-title":"Coronavirus disease 2019-associated immunoglobulin a vasculitis\/Henoch-Sch\u00f6nlein purpura: A case report and review","volume":"49","author":"Jedlowski","year":"2022","journal-title":"J Dermatol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14551","article-title":"Possible association between IgA vasculitis and COVID-19","volume":"34","author":"Sandhu","year":"2021","journal-title":"Dermatol Ther"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-022-05153-w","article-title":"Vasculitis flare after COVID-19: Report of two cases in patients with preexistent controlled IgA vasculitis and review of the literature","volume":"42","author":"Valero","year":"2022","journal-title":"Rheumatol Int"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-0841","article-title":"Vaccination and risk of childhood IgA vasculitis","volume":"142","author":"Piram","year":"2018","journal-title":"Pediatrics"},{"key":"B129","doi-asserted-by":"publisher","first-page":"102707","DOI":"10.1016\/j.autrev.2020.102707","article-title":"Drug-induced IgA vasculitis in children and adults: Revisiting drug causality using a dual pharmacovigilance-based approach","volume":"20","author":"Rasmussen","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00211-3","article-title":"Reactivation of IgA vasculitis after COVID-19 vaccination","volume":"3","author":"Obeid","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz164","article-title":"Severe attack of Henoch-Sch\u00f6nlein purpura with neurological involvement during adalimumab treatment for crohn's disease","volume":"14","author":"Condamina","year":"2020","journal-title":"J Crohns Colitis"},{"key":"B132","article-title":"Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series","volume":"30","author":"Jarrett","year":"2003","journal-title":"J Rheumatol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-202644","article-title":"The first case of henoch-schonlein purpura associated with rosuvastatin: Colonic involvement coexisting with small intestine","volume":"2014","author":"Gonen","year":"2014","journal-title":"BMJ Case Rep"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.3668-19","article-title":"IgA vasculitis developed as an adverse effect of tofacitinib taken for rheumatoid arthritis","volume":"59","author":"Itoh","year":"2020","journal-title":"Intern Med"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2008.00693.x","article-title":"Sibling cases of Henoch-Sch\u00f6nlein purpura in two families and review of literature","volume":"25","author":"Zhang","year":"2008","journal-title":"Pediatr Dermatol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-018-0057-8","article-title":"HLA and kidney disease: from associations to mechanisms","volume":"14","author":"Robson","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1038\/s41598-017-03915-2","article-title":"A genome-wide association study suggests the HLA class II region as the major susceptibility locus for IgA vasculitis","volume":"7","author":"Lopez-Mejias","year":"2017","journal-title":"Sci Rep"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1002\/art.38979","article-title":"HLA-DRB1 association with Henoch-Sch\u00f6nlein purpura","volume":"67","author":"Lopez-Mejias","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-012-2661-4","article-title":"The genetics of Henoch-Sch\u00f6nlein purpura: a systematic review and meta-analysis","volume":"33","author":"He","year":"2013","journal-title":"Rheumatol Int"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000124","article-title":"Genetics of vasculitis","volume":"27","author":"Carmona","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2016.05.009","article-title":"HLA-DRB1 in Henoch-Sch\u00f6nlein purpura: A susceptibility study from north India","volume":"77","author":"Aggarwal","year":"2016","journal-title":"Hum Immunol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10067-007-0640-z","article-title":"HLA class 1 associations in henoch schonlein purpura: increased and decreased frequencies","volume":"27","author":"Peru","year":"2008","journal-title":"Clin Rheumatol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1159\/000189098","article-title":"Complement 4 locus II gene deletion and DQA1*0301 gene: genetic risk factors for IgA nephropathy and Henoch-Sch\u00f6nlein nephritis","volume":"73","author":"Jin","year":"1996","journal-title":"Nephron"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1984.228","article-title":"Complement phenotypes in glomerulonephritis: increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Sch\u00f6nlein purpura","volume":"26","author":"McLean","year":"1984","journal-title":"Kidney Int"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab443","article-title":"Identification of a shared genetic risk locus for Kawasaki disease and immunoglobulin a vasculitis by a cross-phenotype meta-analysis","volume":"61","author":"Carmona","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1067\/S0022-3476(03)00502-X","article-title":"Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Sch\u00f6nlein purpura","volume":"143","author":"Gershoni-Baruch","year":"2003","journal-title":"J Pediatr"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez410","article-title":"Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients","volume":"59","author":"Balci-Peynircioglu","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.5546\/aap.2018.eng.e385","article-title":"MEFV gene mutations and clinical course in pediatric patients with Henoch-Sch\u00f6nlein purpura","volume":"116","author":"Can","year":"2018","journal-title":"Arch Argent Pediatr"},{"key":"B149","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/00325481.2019.1552479","article-title":"MEFV gene variants in children with Henoch-Sch\u00f6nlein purpura and association with clinical manifestations: a single-center Mediterranean experience","volume":"131","author":"Ekinci","year":"2019","journal-title":"Postgrad Med"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-012-2400-x","article-title":"Prevalence and significance of the MEFV gene mutations in childhood Henoch-Sch\u00f6nlein purpura without FMF symptoms","volume":"33","author":"Dogan","year":"2013","journal-title":"Rheumatol Int"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-010-1582-2","article-title":"MEFV E148Q polymorphism is associated with Henoch-Sch\u00f6nlein purpura in Chinese children","volume":"25","author":"He","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-013-2761-9","article-title":"A study on the association between C1GALT1 polymorphisms and the risk of Henoch-Sch\u00f6nlein purpura in a Chinese population","volume":"33","author":"An","year":"2013","journal-title":"Rheumatol Int"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-012-2178-9","article-title":"C1GALT1 polymorphisms are associated with Henoch-Sch\u00f6nlein purpura nephritis","volume":"27","author":"He","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/62896","article-title":"Association of ACE, VEGF and CCL2 gene polymorphisms with Henoch-Sch\u00f6nlein purpura and an evaluation of the possible interaction effects of these loci in HSP patients","volume":"26","author":"Mohammadian","year":"2017","journal-title":"Adv Clin Exp Med"},{"key":"B155","article-title":"A meta-analysis of the association between angiotensin-converting enzyme insertion\/deletion gene polymorphism and Henoch-Sch\u00f6nlein purpura nephritis risk in Asian children","volume":"30","author":"Zhou","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"B156","article-title":"Polymorphism at codon 469 of the intercellular adhesion molecule-1 locus is associated with protection against severe gastrointestinal complications in Henoch-Sch\u00f6nlein purpura","volume":"28","author":"Amoli","year":"2001","journal-title":"J Rheumatol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.11.024","article-title":"Genetics of immunoglobulin-a vasculitis (Henoch-Sch\u00f6nlein purpura): An updated review","volume":"17","author":"Lopez-Mejias","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1739-0","article-title":"Interleukin 8 gene 2767 A\/G polymorphism is associated with increased risk of nephritis in children with Henoch-Sch\u00f6nlein purpura","volume":"32","author":"Tabel","year":"2012","journal-title":"Rheumatol Int"},{"key":"B159","article-title":"Interleukin 1 beta (IL1ss) rs16944 genetic variant as a genetic marker of severe renal manifestations and renal sequelae in Henoch-Sch\u00f6nlein purpura","volume":"34","author":"Lopez-Mejias","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/BOR.0000000000000451","article-title":"An update on the role of epigenetics in systemic vasculitis","volume":"30","author":"Coit","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-015-8495-6","article-title":"Epigenetics and vasculitis: A comprehensive review","volume":"50","author":"Renauer","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Science"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212372","article-title":"Cross-phenotype analysis of immunochip data identifies KDM4C as a relevant locus for the development of systemic vasculitis","volume":"77","author":"Ortiz-Fernandez","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2012.12.009","article-title":"Aberrant histone modifications in peripheral blood mononuclear cells from patients with Henoch-Sch\u00f6nlein purpura","volume":"146","author":"Luo","year":"2013","journal-title":"Clin Immunol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-017-3597-4","article-title":"Vasculitis update: Pathogenesis and biomarkers","volume":"33","author":"Brogan","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-014-2986-2","article-title":"The relationship of neutrophil-to-lymphocyte ratio with gastrointestinal bleeding in Henoch-Sch\u00f6nlein purpura","volume":"34","author":"Makay","year":"2014","journal-title":"Rheumatol Int"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14176","article-title":"Neutrophil-to-lymphocyte ratio: A biomarker for predicting systemic involvement in adult IgA vasculitis patients","volume":"31","author":"Nagy","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.14886","article-title":"Factor XIII as a potential predictor of severe gastrointestinal involvement in henoch schoenlein purpura: A case study research","volume":"56","author":"d'Angelo","year":"2020","journal-title":"J Paediatr Child Health"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.0931-18","article-title":"Successful treatment of IgA vasculitis complicated with bowel perforation and crescentic glomerulonephritis by combination therapy of glucocorticoid, cyclosporine and factor XIII replacement","volume":"57","author":"Koshiba","year":"2018","journal-title":"Intern Med"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.2006.02232.x","article-title":"Factor XIII in Henoch-Sch\u00f6nlein purpura with isolated gastrointestinal symptoms","volume":"48","author":"Kawasaki","year":"2006","journal-title":"Pediatr Int"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpam.2015.06.003","article-title":"Successful treatment of severe gastrointestinal manifestations of Henoch-Sch\u00f6nlein purpura and factor XIII deficiency using cryoprecipitate transfusion","volume":"2","author":"Al Sonbul","year":"2015","journal-title":"Int J Pediatr Adolesc Med"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2009.182394","article-title":"Renal manifestations of Henoch-Sch\u00f6nlein purpura in a 6-month prospective study of 223 children","volume":"95","author":"Jauhola","year":"2010","journal-title":"Arch Dis Child"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.04.034","article-title":"Clinical characteristics of biopsy-proven IgA vasculitis in children and adults: A retrospective cohort study","volume":"94","author":"Villatoro-Villar","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-021-05107-7","article-title":"A systematic review of urine biomarkers in children with IgA vasculitis nephritis","volume":"36","author":"Williams","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13904","article-title":"Analysis of the association between kidney injury biomarkers concentration and nephritis in immunoglobulin a vasculitis: A pediatric cohort study","volume":"23","author":"Dyga","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188718","article-title":"Biomarkers of IgA vasculitis nephritis in children","volume":"12","author":"Pillebout","year":"2017","journal-title":"PLoS One"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01892","article-title":"Vasculitis pathogenesis: Can we talk about precision medicine","volume":"9","author":"Ozen","year":"2018","journal-title":"Front Immunol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"1825849","DOI":"10.1155\/2019\/1825849","article-title":"Apolipoprotein m serum levels correlate with IgA vasculitis and IgA vasculitis nephritis","volume":"2019","author":"Wu","year":"2019","journal-title":"Dis Markers"},{"key":"B179","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13075-019-2089-2","article-title":"Predicting gastrointestinal and renal involvement in adult IgA vasculitis","volume":"21","author":"Hocevar","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.596151","article-title":"Serum bilirubin is correlated with the progression of IgA vasculitis with nephritis","volume":"8","author":"Tan","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B181","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.921864\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T16:38:51Z","timestamp":1676997531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.921864\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":181,"alternative-id":["10.3389\/fimmu.2022.921864"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.921864","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"article-number":"921864"}}